Fina Biotech SL - Product Pipeline Analysis, 2018 Update

Fina Biotech SL - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME135820PD
  • |
  • Pages: 26
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Fina Biotech SL (Fina), formerly Indas Biotech is a biotechnology projects developer that discovers new diagnostic and therapeutic techniques for the healthcare sector. The company finances, selects, develops, and markets biotechnology projects. It offers halosperm that is a kit to determine the degree of DNA fragmentation in human sperm. Fina also provides services to new tools for monitoring, diagnosis, prognosis and treatment of significant diseases and improve human health through the novelty carried out by Spanish researchers companies and research and development centers. The company's research areas include molecular diagnostics and stem cell therapies. It provides investments in the areas of oncology, cardiology and stem cell therapy. The company collaborates with public and private institutions, medical universities, and diagnostic laboratories. Fina is headquartered in Madrid, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Fina Biotech SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Fina Biotech SL Company Overview 4

Fina Biotech SL Company Snapshot 4

Fina Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4

Fina Biotech SL-Pipeline Analysis Overview 6

Fina Biotech SL-Key Facts 6

Fina Biotech SL-Major Products and Services 7

Fina Biotech SL Pipeline Products by Development Stage 8

Fina Biotech SL Ongoing Clinical Trials by Trial Status 10

Fina Biotech SL Pipeline Products Overview 11

Dx Bioenergetic Signature-Breast Cancer 11

Dx Bioenergetic Signature-Breast Cancer Product Overview 11

Dx Bioenergetic Signature-Colon Cancer 12

Dx Bioenergetic Signature-Colon Cancer Product Overview 12

Dx Bioenergetic Signature-Lung Cancer 13

Dx Bioenergetic Signature-Lung Cancer Product Overview 13

Dx Bladder Cancer 14

Dx Bladder Cancer Product Overview 14

Dx Bladder Cancer Clinical Trial 15

Dx Colon Cancer 16

Dx Colon Cancer Product Overview 16

Dx Prostate Cancer 17

Dx Prostate Cancer Product Overview 17

Dx Restenosis 18

Dx Restenosis Product Overview 18

Fina Biotech SL-Key Competitors 19

Fina Biotech SL-Key Employees 20

Fina Biotech SL-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Fina Biotech SL, Recent Developments 22

Jan 26, 2017: Fina Biotech Receives two new patents in 2015 in the United States and in Canada, both belonging to the patent family BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD 22

Jan 26, 2016: Fina Biotech Receives Patents both in US and Canada 22

Appendix 23

Methodology 23

About GlobalData 25

Contact Us 25

Disclaimer 26

List of Figures

Fina Biotech SL Pipeline Products by Equipment Type 5

Fina Biotech SL Pipeline Products by Development Stage 8

Fina Biotech SL Ongoing Clinical Trials by Trial Status 10

List of Tables

Fina Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4

Fina Biotech SL Pipeline Products by Equipment Type 5

Fina Biotech SL Pipeline Products by Indication 5

Fina Biotech SL Ongoing Clinical Trials by Trial Status 5

Fina Biotech SL, Key Facts 6

Fina Biotech SL, Major Products and Services 7

Fina Biotech SL Number of Pipeline Products by Development Stage 8

Fina Biotech SL Pipeline Products Summary by Development Stage 9

Fina Biotech SL Ongoing Clinical Trials by Trial Status 10

Fina Biotech SL Ongoing Clinical Trials Summary 10

Dx Bioenergetic Signature-Breast Cancer-Product Status 11

Dx Bioenergetic Signature-Breast Cancer-Product Description 11

Dx Bioenergetic Signature-Colon Cancer-Product Status 12

Dx Bioenergetic Signature-Colon Cancer-Product Description 12

Dx Bioenergetic Signature-Lung Cancer-Product Status 13

Dx Bioenergetic Signature-Lung Cancer-Product Description 13

Dx Bladder Cancer-Product Status 14

Dx Bladder Cancer-Product Description 14

Dx Bladder Cancer-To evaluate the effectiveness of genetic markers in detection of bladder cancer. 15

Dx Colon Cancer-Product Status 16

Dx Colon Cancer-Product Description 16

Dx Prostate Cancer-Product Status 17

Dx Prostate Cancer-Product Description 17

Dx Restenosis-Product Status 18

Dx Restenosis-Product Description 18

Fina Biotech SL, Key Employees 20

Glossary 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Laboratorios SALVAT SA

Histocell SL

Applied Research using OMIC Sciences SL

Fina Biotech SL,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53520
Site License
USD 1500 INR 107040
Corporate User License
USD 2250 INR 160560



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]